Adial Pharmaceuticals Inc [NASDAQ: ADIL] gained 106.19% on the last trading session, reaching $2.33 price per share at the time. The company report on April 10, 2024 at 8:30 AM that Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in
Adial Pharmaceuticals Inc [NASDAQ: ADIL] gained 59.80% or 1.22 points to close at $3.26 with a heavy trading volume of 77927260 shares. The company report on March 1, 2024 at 7:00 PM that Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds. H.C.
Adial Pharmaceuticals Inc [NASDAQ: ADIL] traded at a high on Wednesday, posting a 85.50 gain after which it closed the day’ session at $1.62. The company report on February 28, 2024 at 9:30 AM that Adial Pharmaceuticals Awarded New Patent from the United States Patent
Adial Pharmaceuticals Inc [NASDAQ: ADIL] closed the trading session at $1.14. The company report on February 13, 2024 at 9:15 AM that Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office. Expands patent estate covering Adial’s unique molecular
Adial pharmaceuticals [NASDAQ:ADIL] a company specialized in developing addictions treatments is in a breakout. This came after the company announced that the FDA has issued an emergency use authorization (EUA) for the company to use Assure/FaStep COVID-19 IgG/IgM Rapid Test Device. This test will be
© 2024, Powered by Smart TechOne
